Flow Health, the London-based company behind a popular women’s health app, announced Tuesday that it has raised more than $200 million in a Series C round backed by General Atlantic.
The funding puts the company’s valuation at over $1 billion, making it what Flo calls “the first purely digital consumer women’s health app to achieve unicorn status.” To date, Flo is known to have raised at least $275 million in funding.
Founded in 2015, Flo has since solidified its position as one of the most widely recognized and used women’s health apps. Though it’s best known as a tool for tracking ovulation and menstrual cycles, the app also provides users with a range of other health information.
Revenue is growing as well: The company says it now has about 70 million monthly active users and 5 million paid subscribers. Bookings are expected to exceed $200 million in 2024, up about 50% from the previous year.
Flo’s funding round is the largest of several big funding rounds for women’s health-focused startups in recent quarters. Using data from Crunchbase, we compiled a sample list of 12 similar funding rounds from the past two years.
Highlights of the list include:
Maven Clinic, a digital health platform for women’s and family health, has raised $292 million to date, including a $90 million Series E in late 2022. Kindbody, a fertility clinic that offers its services as an employee benefit, has raised more than $200 million in equity funding to date. Gynesonics, which is developing an incision-free procedure to treat intrauterine fibroids, has raised more than $300 million in equity funding to date. Natural Cycles, a healthcare app that uses body temperature to track fertility status, raised $55 million in a Series C round in May.
Illustration: Dom Guzman
Stay up to date on recent funding rounds, acquisitions, and more with Crunchbase Daily.